loading
前日終値:
$20.74
開ける:
$20.68
24時間の取引高:
329.96K
Relative Volume:
0.72
時価総額:
$1.02B
収益:
$62.02M
当期純損益:
$-45.65M
株価収益率:
-21.92
EPS:
-0.92
ネットキャッシュフロー:
$-9.60M
1週間 パフォーマンス:
+0.62%
1か月 パフォーマンス:
+8.43%
6か月 パフォーマンス:
+78.19%
1年 パフォーマンス:
+108.22%
1日の値動き範囲:
Value
$19.88
$20.82
1週間の範囲:
Value
$19.52
$21.03
52週間の値動き範囲:
Value
$7.90
$21.03

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
名前
Theravance Biopharma Inc
Name
セクター
Healthcare (1119)
Name
電話
650-808-6000
Name
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
職員
97
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
TBPH's Discussions on Twitter

TBPH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TBPH
Theravance Biopharma Inc
20.18 1.05B 62.02M -45.65M -9.60M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
465.16 118.58B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
751.89 79.40B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
815.50 51.18B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
362.90 48.88B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
338.94 37.49B 4.98B 69.59M 525.67M 0.5197

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-03 開始されました Oppenheimer Outperform
2025-09-12 開始されました B. Riley Securities Buy
2024-08-06 ダウングレード Leerink Partners Outperform → Market Perform
2024-04-12 開始されました BTIG Research Buy
2024-01-08 ダウングレード Evercore ISI Outperform → In-line
2022-05-23 開始されました SVB Leerink Outperform
2021-11-05 アップグレード JP Morgan Underweight → Neutral
2021-09-15 ダウングレード JP Morgan Overweight → Underweight
2021-08-25 ダウングレード Morgan Stanley Overweight → Underweight
2021-08-24 ダウングレード Cowen Outperform → Market Perform
2020-10-14 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-07 開始されました JP Morgan Overweight
2020-06-15 開始されました Morgan Stanley Equal-Weight
2020-05-13 開始されました Cowen Outperform
2020-01-08 繰り返されました H.C. Wainwright Buy
2019-11-06 アップグレード Robert W. Baird Underperform → Neutral
2019-10-29 開始されました H.C. Wainwright Buy
2018-03-29 再開されました Piper Jaffray Overweight
2017-08-17 開始されました Evercore ISI Outperform
2017-06-16 開始されました Cantor Fitzgerald Overweight
2017-05-11 繰り返されました Needham Buy
2016-12-21 開始されました Needham Buy
2016-11-03 開始されました Piper Jaffray Overweight
2016-10-12 ダウングレード Robert W. Baird Neutral → Underperform
2016-08-03 ダウングレード BofA/Merrill Neutral → Underperform
2016-06-20 開始されました Guggenheim Buy
2016-06-20 繰り返されました Leerink Partners Outperform
2016-05-12 開始されました Leerink Partners Outperform
2016-05-05 ダウングレード BofA/Merrill Buy → Neutral
2015-02-03 アップグレード Robert W. Baird Underperform → Neutral
すべてを表示

Theravance Biopharma Inc (TBPH) 最新ニュース

pulisher
06:08 AM

Profit Review: Is Theravance Biopharma Inc affected by consumer sentimentSell Signal & Safe Entry Zone Identification - baoquankhu1.vn

06:08 AM
pulisher
02:42 AM

Theravance Biopharma stock hits 52-week high at $21.01 By Investing.com - Investing.com Nigeria

02:42 AM
pulisher
Jan 22, 2026

Theravance Biopharma stock hits 52-week high at $21.01 - Investing.com

Jan 22, 2026
pulisher
Jan 20, 2026

Theravance Biopharma (NASDAQ:TBPH) Reaches New 1-Year HighHere's What Happened - MarketBeat

Jan 20, 2026
pulisher
Jan 19, 2026

Neurogenic Orthostatic Hypotension (nOH) Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status - GlobeNewswire Inc.

Jan 19, 2026
pulisher
Jan 16, 2026

Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term - sharewise.com

Jan 16, 2026
pulisher
Jan 15, 2026

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Jan 15, 2026
pulisher
Jan 15, 2026

Theravance Biopharma stock hits 52-week high at 20.69 USD By Investing.com - Investing.com Nigeria

Jan 15, 2026
pulisher
Jan 14, 2026

Theravance Biopharma stock hits 52-week high at 20.69 USD - Investing.com

Jan 14, 2026
pulisher
Jan 14, 2026

Trading the Move, Not the Narrative: (TBPH) Edition - Stock Traders Daily

Jan 14, 2026
pulisher
Jan 13, 2026

Theravance Biopharma (NASDAQ:TBPH) Sets New 12-Month HighWhat's Next? - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Theravance Biopharma CEO earns 2026 Honorable Mentor title - Traders Union

Jan 13, 2026
pulisher
Jan 12, 2026

Theravance Biopharma, Inc. Announces Upcoming Phase 3 Data for Ampreloxetine - TradingView — Track All Markets

Jan 12, 2026
pulisher
Jan 09, 2026

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unpacking A 40% Potential Upside - DirectorsTalk Interviews

Jan 09, 2026
pulisher
Jan 08, 2026

What valuation ratios show for Theravance Biopharma Inc. (0TB) stockJuly 2025 Technicals & Reliable Entry Point Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Chart Watch: What valuation ratios show for Theravance Biopharma Inc. (0TB) stockWeekly Trend Recap & Smart Investment Allocation Tips - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Will Theravance Biopharma Inc. stock deliver better than expected guidanceMarket Activity Summary & Verified Momentum Stock Ideas - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Published on: 2026-01-08 18:37:29 - Улправда

Jan 08, 2026
pulisher
Jan 06, 2026

Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Jan 06, 2026
pulisher
Jan 05, 2026

mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jan 05, 2026
pulisher
Jan 03, 2026

Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving AverageWhat's Next? - MarketBeat

Jan 03, 2026
pulisher
Jan 03, 2026

Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving Average – What’s Next? - Defense World

Jan 03, 2026
pulisher
Jan 03, 2026

(TBPH) Volatility Zones as Tactical Triggers - Stock Traders Daily

Jan 03, 2026
pulisher
Jan 03, 2026

Theravance Biopharma (NASDAQ:TBPH) Lowered to Buy Rating by Wall Street Zen - Defense World

Jan 03, 2026
pulisher
Jan 02, 2026

Portfolio Update: Why Theravance Biopharma Inc 0TB stock stays resilient2025 Short Interest & Daily Entry Point Alerts - moha.gov.vn

Jan 02, 2026
pulisher
Jan 02, 2026

Can Theravance Biopharma's Ampreloxetine Fill The Gap In MSA-Related NOH Therapy? - RTTNews

Jan 02, 2026
pulisher
Jan 01, 2026

Market Overview: Is Theravance Biopharma Inc stock trading near support levels2025 Macro Impact & Weekly Return Optimization Plans - Bộ Nội Vụ

Jan 01, 2026
pulisher
Dec 28, 2025

What drives Theravance Biopharma Inc stock priceMarket Insider Reports & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in

Dec 28, 2025
pulisher
Dec 26, 2025

Inspire Investing LLC Purchases New Position in Theravance Biopharma, Inc. $TBPH - MarketBeat

Dec 26, 2025
pulisher
Dec 24, 2025

Here's Why Theravance Biopharma (TBPH) is a Strong Growth Stock - sharewise.com

Dec 24, 2025
pulisher
Dec 23, 2025

(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Dec 23, 2025
pulisher
Dec 22, 2025

Wall Street Analysts Believe Theravance Bio (TBPH) Could Rally 42.15%: Here's is How to Trade - Finviz

Dec 22, 2025
pulisher
Dec 22, 2025

Assenagon Asset Management S.A. Boosts Position in Theravance Biopharma, Inc. $TBPH - MarketBeat

Dec 22, 2025
pulisher
Dec 21, 2025

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Dec 21, 2025
pulisher
Dec 21, 2025

With Theravance Biopharma Stock Surging, Have You Considered The Downside? - Trefis

Dec 21, 2025
pulisher
Dec 20, 2025

Why Theravance Biopharma Inc. stock could outperform in 2025Portfolio Return Report & Verified Entry Point Detection - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

How Theravance Biopharma Inc. stock reacts to global recession fears2025 Market WrapUp & AI Driven Stock Movement Reports - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

How Theravance Biopharma Inc. stock reacts to Fed rate cuts2025 Major Catalysts & Real-Time Volume Triggers - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Will Theravance Biopharma Inc. stock outperform Dow Jones indexMarket Movement Recap & Weekly Stock Breakout Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Theravance Biopharma Inc. stock trading near support levelsWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Will Theravance Biopharma Inc. stock attract ESG investorsMarket Growth Report & Free Community Consensus Stock Picks - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Theravance Biopharma Inc. (0TB) stock a buy before new product rolloutJuly 2025 Earnings & Short-Term Swing Trade Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unveiling a 46.94% Potential Upside for Investors - DirectorsTalk Interviews

Dec 19, 2025
pulisher
Dec 15, 2025

Theravance Biopharma, Inc. (TBPH) Discusses Ampreloxetine Phase 3 Program and Unmet Need in Neurogenic Orthostatic Hypotension with Multiple System AtrophySlideshow (NASDAQ:TBPH) 2025-12-15 - Seeking Alpha

Dec 15, 2025
pulisher
Dec 14, 2025

Theravance Biopharma (NASDAQ:TBPH) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Dec 14, 2025
pulisher
Dec 12, 2025

History Review: How Theravance Biopharma Inc. stock reacts to global recession fearsRate Hike & Scalable Portfolio Growth Methods - moha.gov.vn

Dec 12, 2025
pulisher
Dec 12, 2025

Why The Narrative Around Theravance Biopharma Is Shifting After Trelegy Monetization And Strategic Review - Yahoo Finance

Dec 12, 2025
pulisher
Dec 12, 2025

Camber Capital Management LP Trims Stock Position in Theravance Biopharma, Inc. $TBPH - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

How (TBPH) Movements Inform Risk Allocation Models - Stock Traders Daily

Dec 12, 2025
pulisher
Dec 11, 2025

Hsbc Holdings PLC Takes Position in Theravance Biopharma, Inc. $TBPH - MarketBeat

Dec 11, 2025
pulisher
Dec 10, 2025

Theravance Bio (TBPH) Down 3.7% Since Last Earnings Report: Can It Rebound? - sharewise.com

Dec 10, 2025

Theravance Biopharma Inc (TBPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$101.58
price down icon 3.31%
$33.80
price up icon 2.05%
$118.73
price down icon 0.07%
$116.68
price down icon 1.56%
$154.93
price down icon 3.49%
biotechnology ONC
$339.98
price up icon 0.16%
大文字化:     |  ボリューム (24 時間):